Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daniel Haldar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|January 28, 2025
Dual checkpoint blockade for microsatellite instability-high colorectal cancerS Daniel Haldar, Scott Kopetz
Annual Review of Medicine|December 5, 2025
Oncogene Mutations: The Shared Antigen Vaccines That Work?Rodrigo Paredes, S Daniel Haldar, Shubham Pant, et al.
The Oncologist|February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic CancerS Daniel Haldar, Fen Saj, So Jung Hong, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|January 28, 2025
Dual checkpoint blockade for microsatellite instability-high colorectal cancerS Daniel Haldar, Scott Kopetz
Annual Review of Medicine|December 5, 2025
Oncogene Mutations: The Shared Antigen Vaccines That Work?Rodrigo Paredes, S Daniel Haldar, Shubham Pant, et al.
The Oncologist|February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic CancerS Daniel Haldar, Fen Saj, So Jung Hong, et al.
Nature Communications|June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trialHejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Nature Communications|April 15, 2026
Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Girgis, et al.
Nature Communications|February 10, 2026
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trialAmanda L Huff, S Daniel Haldar, Alexander A Gergis, et al.
Pageof 1